Edition:
United States

Agios Pharmaceuticals Inc (AGIO.O)

AGIO.O on Nasdaq

41.20USD
23 Jan 2017
Change (% chg)

$-1.08 (-2.55%)
Prev Close
$42.28
Open
$42.24
Day's High
$42.56
Day's Low
$40.22
Volume
740,505
Avg. Vol
813,425
52-wk High
$67.74
52-wk Low
$33.50

Select another date:

Mon, Jan 9 2017

BRIEF-Agios provides early-stage data on AG-120 in glioma, chondrosarcoma patients

* Agios announces phase 1 data from dose expansion cohorts of AG-120 in patients with IDH1 mutant positive glioma and chondrosarcoma Source text for Eikon: Further company coverage:

BRIEF-Agios posts Q3 shr loss $1.63

* Agios Pharmaceuticals inc - now expects to end 2016 with more than $550 million of cash, cash equivalents and marketable securities

BRIEF-Agios Pharma says Celgene expects to submit NDA to U.S. FDA for enasidenib

* Celgene corporation expects to submit a new drug application to U.S. FDA for Enasidenib (ag-221)

BRIEF-Agios Pharmaceuticals appoints Andrew Hirsch as chief financial officer

* Glenn Goddard, senior vice president of finance, will be leaving company at end of September to pursue other opportunities

BRIEF-Agios Pharmaceuticals reports qtrly loss per share $1.47

* Collaboration revenue was $7.0 million for quarter ended June 30, 2016, compared to $13.2 million for comparable period in 2015

Select another date: